Literature DB >> 30814074

The Effect of Triggering Receptor Expressed by Myeloid Cells 2 Modified Bone Marrow Mesenchymal Stem Cells on Alzheimer's Disease-Mouse Model.

Yun Yang1,2,3, Xiaomu Wu1,2,3, Xinhui Qu1,2,3, Xinrong Wang4, Chaoqun Luo1,2,3, Lingjuan Li1,2,3, Kunnan Zhang5,2,3.   

Abstract

OBJECTIVE: This study aims to explore the effect of TREM2 modified BMSCs on hippocampus of AD mice.
METHODS: Mouse bone marrow mesenchymal stem cells were isolated and identified. APP/PS1 double transgenic mice were confirmed to be AD model and divided into 4 groups: control group, MSCs group, MSCs+vector group and MSCs+pEGFP-TREM2 group.
RESULTS: The incubation period and the number of errors in the MSCs+pEGFP-TREM2 group were significantly decreased than that of control group after 3 days. The quantity and area of Aβ deposition in MSCs+pEGFP-TREM2 group were significantly smaller than that of control group. Aβ40 and Aβ42 levels were significantly decreased most in MSCs+pEGFP-TREM2 group. The expression levels of TREM2 and DAP12 significantly increased in the MSCs+pEGFP-TREM2 group.
CONCLUSIONS: TREM2 modified bone marrow MSCs affected the ability of learning and memory of AD model mice and this mechanism may be related to the expression of TREM2 and DAP12 genes.
© 2019 by the Association of Clinical Scientists, Inc.

Entities:  

Keywords:  Alzheimer’s disease; DAP12; MSCs; Triggering receptor expressed by myeloid cells 2 (TREM2)

Mesh:

Substances:

Year:  2019        PMID: 30814074

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  2 in total

Review 1.  Therapeutic utility of mesenchymal stromal cell (MSC)-based approaches in chronic neurodegeneration: a glimpse into underlying mechanisms, current status, and prospects.

Authors:  Mohaddeseh Rahbaran; Angelina Olegovna Zekiy; Mahta Bahramali; Mohammadsaleh Jahangir; Mahsa Mardasi; Delaram Sakhaei; Lakshmi Thangavelu; Navid Shomali; Majid Zamani; Ali Mohammadi; Negin Rahnama
Journal:  Cell Mol Biol Lett       Date:  2022-07-16       Impact factor: 8.702

2.  Tanshinone ΙΙA-Incubated Mesenchymal Stem Cells Inhibit Lipopolysaccharide-Induced Inflammation of N9 Cells through TREM2 Signaling Pathway.

Authors:  Nanqu Huang; Juan Huang; Fei Feng; Zhisheng Ba; Yuanyuan Li; Yong Luo
Journal:  Stem Cells Int       Date:  2022-03-04       Impact factor: 5.443

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.